|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product sales, net | |||||
| Product supply revenue | |||||
| Collaborative development revenue | |||||
| Licensing revenue | |||||
| Non-cash royalty revenue related to the sale of future royalties | |||||
| Total revenues | |||||
| Costs and operating expenses | |||||
| Cost of sales | |||||
| Product sales, net | |||||
| Other cost of revenue | |||||
| Total cost of sales | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total costs and operating expenses | |||||
| Loss from operations | |||||
| Interest expense | |||||
| Non-cash interest expense related to the sale of future royalties | |||||
| Other income, net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Unrealized gains (losses) on available-for-sale securities | |||||
| Comprehensive loss | |||||
| Net loss per share of common stock - basic (in dollars per share) | |||||
| Net loss per share of common stock - diluted (in dollars per share) | |||||
| Shares used in computing net loss per share - basic (in shares) | |||||
| Shares used in computing net loss per share - diluted (in shares) |
Loading...